PDL-1 POSITIVE

Clinical trials for PDL-1 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new PDL-1 POSITIVE trials appear

Sign up with your email to follow new studies for PDL-1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Three-Pronged attack on tough breast cancer begins human testing

Disease control Not yet recruiting

This trial is testing a new combination of three drugs as the first treatment for people with advanced triple-negative breast cancer that tests positive for a marker called PD-L1. The goal is to see if the combination is safe and can shrink tumors and control the cancer. It will …

Matched conditions: PDL-1 POSITIVE

Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

PDL-1 POSITIVE

Get alerted when new PDL-1 POSITIVE trials appear

Three-Pronged attack on tough breast cancer begins human testing